Table 2

Summary of specimen preparation

n (%)Patients with advanced OC, n=482
Biopsy source
Newly obtained*19 (3.9)
Archival463 (96.1)
Biopsy site
Primary tumour476 (98.8)
Lymph node3 (0.6)
Metastatic lesion†3 (0.6)
Biospecimen type
Biopsy138 (28.6)
Surgical resection344 (71.4)
  • *Defined as tissue collected within 6 weeks of the PD-L1 test.

  • †Metastatic lesion samples were decalcified bone specimens.

  • OC, oesophageal cancer; PD-L1, programmed death ligand 1.